Video

Medicare Part D and Oncology

Author(s):

Lauren Santye, Assistant Editor

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses how the shift to Medicare Part D could impact patients undergoing treatment for cancer.

Marc O'Connor, COO and chief strategy officer at Curant Health, discusses how the shift to Medicare Part D could impact patients undergoing treatment for cancer.

Related Videos
Pharmacist helping a patient with medication -- Image credit: Clayton D/peopleimages.com | stock.adobe.com
Patient receiving cancer treatment infusion -- Image credit: UlrikaArt | stock.adobe.com
Related Content
Pharmacist, customer or support in shop with medicine, shopping with professional help. Pharmacy, people or together for healthcare service with advice for dosage, pill information for woman with flu
March 31st 2025

Expert Q&A: Role of Pharmacists in COVID-19 Care, Prevention Continues to Evolve

Luke Halpern, Assistant Editor Corey Frederick, PharmD, BCPS, BCIDP, CPh
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Herpes Zoster as an Early Indicator of HIV: Clinical Insights
March 31st 2025

Herpes Zoster as an Early Indicator of HIV: Clinical Insights

Emilia Welch, PharmD, MBA
Pharmacy focus podcast
March 28th 2025

From Screening to Survival: The Pharmacist’s Role in Colorectal Cancer

Alexandra Gerlach, Associate Editor
X-ray image of liver -- Image credit: Sebastian Kaulitzki | stock.adobe.com
March 31st 2025

BEAM-302 Receives FDA IND Clearance for AATD, a Genetic Disorder Affecting the Liver and Lungs

Gillian McGovern, Associate Editor
ACC 2025: Lower-Dose Apixaban Is Effective, Safer Than Full Dose for Preventing VTE Recurrence in Patients With Cancer
March 29th 2025

ACC 2025: Lower-Dose Apixaban Is Effective, Safer Than Full Dose for Preventing VTE Recurrence in Patients With Cancer

Aislinn Antrim, Managing Editor